Cipher Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	17.36	11.55	20.38	26.64	7.76	4.39
Depreciation & Amortization	6.94	4.02	1.23	0.99	0.7	1.21
Stock-Based Compensation	1.59	1.07	1.19	0.4	0.14	0.12
Other Adjustments	-6.91	-6.04	-3.53	-14.27	0.54	4.26
Change in Receivables	3.09	-8.77	1.71	-0.14	2.56	-0.34
Changes in Inventories	2.36	3.6	-0.83	-0.5	-0.76	0.15
Changes in Accounts Payable	-1.34	1.28	0.53	-1.45	-1.23	0.28
Changes in Income Taxes Payable	0.01	0.05	-4.97	-0.85	3.59	1.53
Changes in Unearned Revenue	7.67	12.79	0.27	-0.19	0.14	0.2
Changes in Other Operating Activities	-0.75	0.01	0.01	0.1	0.37	-0.1
Operating Cash Flow	29.88	19.55	16	10.73	13.81	11.69
Operating Cash Flow Growth	128.50%	22.17%	49.18%	-22.36%	18.16%	31.95%
Capital Expenditures	-0.01	-0.04	-0.02	-0.08	-	-0.01
Purchases of Intangible Assets	-	-	-	-	-	-0.75
Payments for Business Acquisitions	-	-80	-0.12	-	-	-
Investing Cash Flow	0.04	-80.04	-0.14	-0.08	-	-0.76
Short-Term Debt Repaid	-7.5	-	-	-	-	-
Net Short-Term Debt Issued (Repaid)	-7.5	-	-	-	-	-
Long-Term Debt Issued	-	40	-	-	-	-
Long-Term Debt Repaid	-	-	-	-	-	-7.67
Net Long-Term Debt Issued (Repaid)	-	40	-	-	-	-7.67
Issuance of Common Stock	0.11	0.15	0.43	0.13	0.08	0.04
Repurchase of Common Stock	-3.72	-0.18	-5.56	-1.99	-1.72	-0.08
Net Common Stock Issued (Repurchased)	-3.61	-0.02	-5.13	-1.86	-1.64	-0.04
Other Financing Activities	-0.34	-0.68	-0.11	-0.06	-0.83	-0.43
Financing Cash Flow	-30.96	39.3	-5.24	-1.91	-2.47	-8.13
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.06	-0.79	0.38	-0.44	0.06	-
Net Cash Flow	-1.04	-21.2	10.61	8.73	11.34	2.8
Free Cash Flow	29.87	19.5	15.98	10.64	13.81	11.68
Free Cash Flow Growth	53.17%	22.05%	50.11%	-22.95%	18.26%	44.85%
FCF Margin	59.68%	58.45%	75.50%	51.48%	62.95%	54.06%
Free Cash Flow Per Share	-	0.77	0.63	0.00	0.51	0.43
Levered Free Cash Flow	24.74	73.24	16.6	24.65	10.58	-0.02
Unlevered Free Cash Flow	35.99	41.75	12.34	23.66	11.1	7.78

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.